Ann: Dr Ron Weinberger appointed Executive Chairman - Updated, page-2

Shuffling chairs here or getting serious??

"Ron has been Non-Executive Chairman of HeraMED since August 2018 during which time he has assisted management in progressing the business from its developmental phase to the current phase that sees HeraMED on the cusp of broader commercialisation, particularly in the key target markets of USA and Australia."

Are we going to get extra special Ron now?  Has he been holding things back since 2018 and now we get full access to his black book??

Not sure on how these games play out, but the only paragraph that I was keen on was:

"As HeraMED Executive Chairman, Ron will bring his significant experience to all aspects of the commercialisation process including manufacturing, sales and marketing, a focus on non-dilutive funding as well as revenue growth all with a view to the creation of shareholder value. "

Non dilutive funding, bring it on ASAP please Dr. Ron.

Shareholder value, yes well there would be less than 1% of holders that is above there average buy in price, this bit wont be too hard to achieve.

Hope he can deliver on both of those "views".

Regards to all, and stay in your crease...

Just another opinion.

TCG